Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Oct 22, 2019 at 12:05 PM EDT

Eton Pharma Wins Big With FDA Hypotension Treatment Approval

Eton Pharma shares jumped on Tuesday after the firm announced that the FDA has approved Biorphen for treatment of hypotension.

Chris Lange | Oct 22, 2019 at 10:20 AM EDT

Why Biogen’s Alzheimer’s Study Is Overshadowing Its Big Earnings Beat

Biogen released its third-quarter financial results and Alzheimer’s trial news before the markets opened on Tuesday.

Chris Lange | Oct 21, 2019 at 10:50 AM EDT

Big Step Forward in HER2-Positive Breast Cancer Trial

Seattle Genetics shares jumped on Monday after the firm announced positive results from its midstage breast cancer trial.

Jon C. Ogg | Oct 19, 2019 at 6:45 AM EDT

How Biotech and Big Pharma Have Upside Heading Into Earnings

Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.

Paul Ausick | Oct 17, 2019 at 12:27 PM EDT

Opioid Crisis Has Cost US Economy $631 Billion

Over the past four years, the economic cost of the opioid epidemic has cost the United States some $631 billion.…

Chris Lange | Oct 16, 2019 at 12:15 PM EDT

A Crucial Major Depressive Disorder Study Is About to Be Underway

Axsome Therapeutics shares made a handy gain on Wednesday after the firm announced that it has completed patient enrollment in…

Chris Lange | Oct 16, 2019 at 9:45 AM EDT

Are Shareholders Getting Enough in the Achillion Acquisition?

Achillion Pharmaceuticals shares skyrocketed on Wednesday morning on news that the firm would be acquired by Alexion Pharmaceuticals.

Chris Lange | Oct 15, 2019 at 12:35 PM EDT

Why This Neuromuscular Disorder Study Could Be the Next Big Thing

Reata Pharma shares jumped on Tuesday after the firm announced positive results from its midstage neuromuscular disorder drug trial.

Chris Lange | Oct 15, 2019 at 10:29 AM EDT

Johnson & Johnson Offers a Strong Start to Earnings Season

Johnson & Johnson reported better than expected quarterly results before the markets opened on Tuesday.

Chris Lange | Oct 15, 2019 at 10:10 AM EDT

UnitedHealth Helps Save the Dow With Q3 Earnings

UnitedHealth reported better than expected third-quarter financial results before the markets opened on Tuesday.

Chris Lange | Oct 14, 2019 at 1:00 PM EDT

What to Watch in the UnitedHealth Earnings Report Tuesday

UnitedHealth is set to release its third-quarter financial results before the markets open on Tuesday, and analysts are looking for…

Chris Lange | Oct 14, 2019 at 12:10 PM EDT

What to Expect When Johnson & Johnson Reports Tuesday

Johnson & Johnson is scheduled to report its most recent quarterly results before the markets open on Tuesday, and analysts'…

Chris Lange | Oct 14, 2019 at 10:05 AM EDT

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Allergan has finally announced that its shareholders have voted to approve the company’s acquisition of AbbVie. The acquisition is expected…

Chris Lange | Oct 14, 2019 at 10:00 AM EDT

New Osteoarthritis Treatment Has to Wait Even Longer for FDA Approval

Flexion Therapeutics has announced that the FDA needs additional time to complete the review of its osteoarthritis knee pain treatment.

Chris Lange | Oct 12, 2019 at 2:51 PM EDT

Short Sellers Hike Bets in Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The September 30 short interest data…

1 … 80 81 82 83 84 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Eton Pharma Wins Big With FDA Hypotension Treatment Approval

Why Biogen’s Alzheimer’s Study Is Overshadowing Its Big Earnings Beat

Big Step Forward in HER2-Positive Breast Cancer Trial

How Biotech and Big Pharma Have Upside Heading Into Earnings

Opioid Crisis Has Cost US Economy $631 Billion

A Crucial Major Depressive Disorder Study Is About to Be Underway

Are Shareholders Getting Enough in the Achillion Acquisition?

Why This Neuromuscular Disorder Study Could Be the Next Big Thing

Johnson & Johnson Offers a Strong Start to Earnings Season

UnitedHealth Helps Save the Dow With Q3 Earnings

What to Watch in the UnitedHealth Earnings Report Tuesday

What to Expect When Johnson & Johnson Reports Tuesday

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

New Osteoarthritis Treatment Has to Wait Even Longer for FDA Approval

Short Sellers Hike Bets in Major Biotechs

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

Health and Healthcare Articles

All Health and Healthcare Articles

Eton Pharma Wins Big With FDA Hypotension Treatment Approval

Why Biogen’s Alzheimer’s Study Is Overshadowing Its Big Earnings Beat

Big Step Forward in HER2-Positive Breast Cancer Trial

How Biotech and Big Pharma Have Upside Heading Into Earnings

Opioid Crisis Has Cost US Economy $631 Billion

A Crucial Major Depressive Disorder Study Is About to Be Underway

Are Shareholders Getting Enough in the Achillion Acquisition?

Why This Neuromuscular Disorder Study Could Be the Next Big Thing

Johnson & Johnson Offers a Strong Start to Earnings Season

UnitedHealth Helps Save the Dow With Q3 Earnings

What to Watch in the UnitedHealth Earnings Report Tuesday

What to Expect When Johnson & Johnson Reports Tuesday

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

New Osteoarthritis Treatment Has to Wait Even Longer for FDA Approval

Short Sellers Hike Bets in Major Biotechs

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up